Oral transmucosal drug delivery systems

Indian Drugs

Volumn 41, Issue 2, 2004, Pages 63-75

  Pramodkumar, T M ^a   Shivakumar, H G ^a   Desai, K G ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951655867     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Shojaei A.H., Buccal Mucosa as a route for Systemic drug delivery - A review, J.Pharm. Pharmaceutical Sci., 1998,1(1), 15
2. Janet A.H.Hoogstraate and Philip W. Wertz, Pharm. Sci. Tech., 1998, 1(7), 309
3. Harris D. and Robinson J.R., Drug delivery via the mucous membrane of the oral cavity, J.Pharm. Sci., 1992, 81(1), 1
4. Padma V. D. and Manisha H.A., "Oral transmucosal drug delivery", in Jain N.K. Controlled and Novel Drug Delivery, First Edn. CBS Publishers and Distributors., New Delhi, 1997, 52
5. Chowdary K.P.R. and Srinivas L., Mucoadhesive drug delivery systems: review of current status, Indian drugs, 2000,37(9), 400
6. Duchene D., Touchard F., and Peppas N.A., Pharmaceutical and medical aspects of bioadhesive system for drug administration, Drug Dev. Ind. Pharm. 1988,14,283
7. De Ascentiis A. Colombo P. Peppas NA., Screening of potentially mucoadhesive polymer microparticles in contact with rat intestinal mucosa., Eu.J.Pharm. Biopharm., 1995, 41,229.
8. Bremecker K.D., Model for the determination of the adhesive time of mucosal adhesive ointments in vitro., Pharmazeutische Industrie., 1983,45, 417.
9. Ahuja A., Khar R.K. and Ali J., Mucoadhesive drug delivery systems, Drug Dev. Ind. Pharm., 1997,23(5), 489.
10. Ch'ng H.S., Park H., Kelly P. and Robinson, J.R., Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers, J.Pharm. Sci., 1985,74,399.
11. Ch'ng HS. Park H. Kelly P. Robinson, JR., Bioadhesive polymers as platforms for oral controlled drug delivery. Part 2. Synthesis and evaluation of some swelling, water insoluble bioadhesive polymers., J.Pharm. Sci., 1985, 74,399.
12. Kamath K.R. and Park K In Swarbrick,J. and Boylan, J.C., Eds. Encyclopedia of Pharmaceutical Technology, Vol.10, Marcel Dekker, New York, 1994, 133.
13. Lehr CM. Bouwstra, JA. Schacht, EH. Junginger, HE., In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers., Int.J. Pharm., 1992,78, 43.
14. Longer MA. Robinson JR., Fundamental aspects of bioadhesion., Pharm. Int., 1986,7, 114
15. Ishida M., Muchida Y., Nambu N., and Nagai T., New mucosal dosage form of insulin, Chem. Pharm. Bull., 1981,29,810.
16. Ponchel G., Touchgard F., Wouessidijewe D., Dechene, D. and Peppas, N.A., Int.J. Pharm. 1987, 38,65.
17. Lehr CM. Bouwstra JA. Spies F. Onderwater J. Junginger, HE. Visualization studies of the mucoadhesive interface. J.Control. Rel., 1992, 18, 249.
18. Saettone MF. Giannaccini B. Chetoni P. Torracca MT. Monti D. Evaluation of high- and low-molecular-weight fractions of sodium, hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine., Int. J.Pharm., 1991, 72(27): 131
19. Agarwal SP., Ahuja A., Preparation and evaluation of muco-adhesive buccal tablets of hydralazine hydrochloride, Ind. J. Pharm. Sci. 1997, 59(3): 135.
20. Rillosi M. and Buckton G., Modeling mucoadhesion by use of surface energy terms obtained by the Lewis acid- Lewis base approach, Int.J.Pharm., 1995, 117,75.
21. Mortazavi SA. and Smart JD., Factors influencing gelstrengthening at the mucoadhesive-mucus interface., J.Pharm. Pharmacol., 1994 , 46, p 86.
22. Ishida M., Nambu N. and Nagai T., Ointment type oral mucosal dosage form of carbopol containing prednisolone for the treatment of aptha, Chem. Pharm. Bull., 1983,31, 1010.
23. Sam AP. Van Den Heuij JT. Tukker J., Mucoadhesion of both film-forming and non-film-forming polymeric materials as evaluated with the Wilhelmy plate method. Int. J. Pharm., 1992,79,97.
24. Smart J.D., and Kellaway I.W., Pharmaceutical factors influencing the rate of gastrointestinal transit in an animal model. Int. J.Pharm., 1989, 53, 79.
25. Park H. and Robinson J.R., Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion, Int. J.Pharm., 1984,19,107.
26. Mikos A.G., and Robinson R., in Bioadhesive Drug delivery Systems, Lenaerts, V. and Gurny, R., Eds. CRC Press, Boca Raton, FL,1990,25.
27. Mortazavi S.A., Carpenter B.G.and Smart J.D., Investigation of the rheological behavior of the mucoadhesive/mucosal interface.Int.J. Pharm., 1992,83, 221.
28. Mortazavi S.A., Carpenter B.G.and Smart J.D., Comparative study on the role played by mucus glycoproteins in the rheological behavior of the mucoadhesive/mucosal interface, Int.J. Pharm., 1993,94, 195.
29. Mortazavi S.A., Carpenter B.G. and Smart J.D., Factors influencing gel-strengthening at the mucoadhesivemucus interface., J. Pharm. Pharmacol., 1994,46, 86.
30. Ho NF. Day JS. Barsuhn CL. Burton PS. Raub TJ., Biophysical model approaches to mechanistic transepithelial studies of peptides., J. Control. Rel., 1990, 11, 3.
31. Rao K.V.R., and Buri P., Novel in situ method to test polymers and coated microparticles for bioadhesion., Int. J. Pharm., 1989, 52,265.
32. Park K., New approach to study mucoadhesion: colloidal gold staining., Int.J Pharm., 1989, 53,209.
33. Hassan E.E.and Gallo J.M., Simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength., Pharm. Res., 1990, 7, 491.
34. Khosla R.and Davis S.S., Effect of polycarbophil on the gastric emptying of pellets., J.Pharm.Pharmacol., 1987,39,47.
35. Devarajan P.V. and Gandhi A. in Invitro and Invivo studies of Oral Transmucosal Drug delivery in Advances in controlled drug delivery edited by N.K.Jain, CBS Publishers & distributors New Delhi, first edition 2001, 70.
36. Dowty M.E., Knuth K.E., Irons B.K. and Robinson J.R., Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro, Pharm. Res., 1992, 9,1113.
37. Hill M.W. and Squier C.A., The permeability of oral palatal mucosa maintained in organ culture, J. Anat., 1979,128,169.
38. Tavakoli-Saberi M.R. and Audus K.L., Cultured buccal epithelium: an in vitro model derived from the hamster pouch for studying drug transport and metabolism, Pharm. Res., 1989,6,160.
39. Tavakoli-Saberi M.R., Williams A. and Audus K.L., Nicotine permeation through buccal cultures, Pharm. Res., 1989,6,S-197.
40. Leipold H.R. and Quadros E., Nicotine permeation through buccal cultures, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 1993, 20, 242.
41. Beckett A.H. and Triggs E.J., Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes, J. Pharm. Pharmacol., 1967,19,31.
42. Schurmann W. and Turner P., A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the beta-blocking drugs atenolol and propranolol J. Pharm. Pharmacol., 1978.,30,137.
43. Tucker I.G., A method to study the kinetics of oral mucosal drug absorption from solutions, J. Pharm. Pharmacol., 1988, 40,679 .
44. Gonzalez-Younes I., Wagner J.G., and Gaines D.A., Absorption of flubriprofen through human buccal mucosa, J. Pharm. Sci., 1991, 80,820.
45. McQuinn R.L., Kvam D.C., Maser M.J., Miller A.L., and Oliver A., A., Sustained oral mucosal delivery in human volunteers of buprenorphine from thin non-eroding mucoadhesive polymeric disks, J. Control. Rel., 1995, 34, 243.
46. Benes L., Transmucosal oral controlled-release, transdermal drug administration in human subjects: A crossover study with melatonin, J. Pharm. Sci., 1997, 86,1115.
47. Coutel-Egros A., Maitani Y., Veillard M., Machida Y., Nagai, T. Combined effects of pH, cosolvent and penetration enhancers on the in vitro buccal absorption of propranolol through excised hamster cheek pouch., Int. J.Pharm., 1992, 84, 117.
48. Yamahara H. and Lee V.H., Drug Metabolism in the Oral Cavity, Adv. Drug Del. Rev., 1993, 12,25.
49. Save T., Venkitachalam P., Bioadhesive tablets of Nifedipine: Standardization of a novel buccoadhesive erodible carrier, Drug Dev. Ind. Pharm., 1994, 20, 3005.
50. Save T., Shah U.M., Ghamande A.R. and Venkitachalam P., Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine., J.Pharm. Pharmacol., 1994,46,192.
51. Save T. Venkitachalam P. Studies on solid dispersions of nifedipine., Drug Dev. Ind. Pharm., 1992, 18(15), 1663.
52. Baichwal MR. Deshpande SG. Singh PK. Venkitachalam P., Studies on polymeric films for transdermal use., Ind. J.Pharm. Sci., 1988,50, 153.
53. Nozaki U., Kakumato M., Ohta M. and Yukmatsu K., A new transmucosal therapeutic system: overview of formulation development and in vitro/ in vivo clinical performance, Drug Dev. Ind. Pharm. 1993, 19 (1&2), 221.
54. Danjo K., Kitamura Y., Miyagawa Y. and Otsuka A., Release of isosorbide dinitrate from polymer film dosage forms and absorption of this drug through the oral mucosa of rats., Chem. Pharm. Bull., 1994, 42, 2126.
55. Guptha A., Garg S. and Khar R.K., Interpolymer complexation and its effect on bioadhesion strength and dissolution characteristics of buccal drug delivery systems, Drug Dev. Ind. Pharm., 1994, 20,315.
56. Khanna R. Agarwal SP. Ahuja A., Preparation and evaluation of mucoadhesive buccal films of clotrimazole, for oral candida infections., Ind. J. Pharm.Sci., 1997,59,299.
57. Balamurugan K., Pandit J.K., Choudary, P.K. and Balasubramanium J., Ind.J.Pharm. Sci., 2001,63(6),473.
58. Schor J.M., Davis S.S., Nigalaye A. and Bolton Susadrin transmucosal tablets (nitroglycerin in Synchron controlled release base)., Drug Dev. Ind. Pharm., 1983,9,1359.
59. Dinsheet, Development and evaluation of buccal dosage forms of hydralazine Hcl using bioadhesive polymers, M.Pharm. Dissertation, Jamia Hamdard, New Delhi (1994).
60. Guo J.H., Bioadhesive polymer buccal patches for buprenorphine controlled delivery: formulation, in vitro adhesion and release properties, Drug Dev. Ind. Pharm., 1994, 20,315.
61. Watanabe K. Yakou S. Takayama K. Isowa K. Nagai T., Rectal absorption and mucosal irritation of rectal gels containing buprenorphine hydrochloride prepared with water-soluble dietary fibers, xanthan gum and locust bean gum., J.Control. Rel., 1996, 38, 27.
62. Ishida M, Nambu M. and Nagai T., Highly viscous gel ointment containing carbopol for application to the oral mucosa, Chem. Pharm. Bull., 1983a, 31, 4561.
63. Lejoyeux F., Ponchel G., Wouessidijewe D., Peppas N.A. and Dechene D., Bioadhesive tablets: influence of the testing medium composition on bioadhesion., Drug Dev. Ind. Pharm., 1989,15,2037.
64. Bouckaert S. Lefebvre RA. Remon JP. In vitro/in vivo correlation of the bioadhesive properties of a buccal bioadhesive miconazole slow-release tablet., Pharm. Res. , 1993, 10, 853.
65. Khurana R., Alka A.and Khar R.K., Development and evaluation of mucoadhesive films of miconazole nitrate, Ind. J.Pharm. Sci., 2000(6), 447.
66. Rajesh K., Development and evaluation of mucoadhesive buccal tablets and films of clotrimazole for oral candidiasis, M. Pharm Dissertation, Jamia Hamdard, New Delhi 1995.
67. Aungst B.J. and Rogers N.J., Comparision of the effects of various transmucosal absorption promoters on buccal insulin delivery, Int. J. Pharm., 1989, 53,227.
68. Gandhi R. B. and Robinson J.R., Mechanisms of penetration enhancement for transbuccal delivery of salicylic acid, Int. J. Pharm., 1992, 85,129.
69. Hoogstraate A.J., Verhoef J.C., Tuk B., Pijpers A., van leengoed L., Vheijden J.H., Junjinger H.E., and Bodde H.E., Buccal delivery of fluorescein isothiocyanatedextran 4400 and the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs, J. Control. Rel., 1996,1,77.
70. Steward A., Bayley D.L. and Howes C., The effect of enhancers on the buccal absorption of hybrid (BDBB) alpha-interferon, Int. J. Pharm., 1994,104, 145.
71. Senel S., Hoogstraate A.J., Spies F., Verhoef J.C., Bos-van Geest A., Junginger H.E. and Bodde H.E., Enhancement of in vitro permeability of porcine buccal mucosa by bile salts: kinetic and histological studies, J. Control. Rel., 1994, 32,45.
72. Hoogstraate A.J., Senel S., Cullander C., Verhoef J., Junginger H.E. and Bodde H.E., Effects of bile salts on transport rates and routes of FTIC-labelled compounds across porcine buccal epithelium in vitro, J. Control. Rel., 1996, 40,211.
73. Siegel I.A., Izutsu K.T., Burkhart J., Transfer of alcohols and ureas across the oral mucosa measured using streaming potentials and radioisotopes., J. Pharm. Sci., 1976, 65, 129.
74. Squier CA. Wertz PW., Permeability and the pathophysiology of oral mucosa., Adv. Drug Del. Reviews., 1993 12, 13.
75. Squier C.A. and Wertz P.W., Structure and function of the oral mucosa and implications for drug delivery, in eds. M.J. Rathbone, Oral Mucosal Drug Delivery, Marcel Dekker, Inc., New York, New York, 1996, 1.
76. Ch'ng H.S., Park H., Kelly and Robinson J.R., Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers, J.Pharm. Sci.,1985,74,399.
77. Gandhi R.E. and Robinson J.R., Bioadhesion in drug delivery, Ind. J. Pharm. Sci., 1988, 50,145.
78. Sanzgiri Y.D., Benedetti L., and Stella V.J., Evaluation of mucoadhesive properties of hyaluronic caid benzyl esters, Int. J. Pharm., 1994, 107,91.
79. Lehr C.M., Bouwstra J.A., Schact E.H. and Junginger H.E., In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, Int. J. Pharm., 1992, 78:43-48.
80. Leung SH. Robinson JR., Contribution of anionic polymer structural features to mucoadhesion., J. Control. Rel., 1988, 5, 223.
81. Nagai T. and Machida Y., Buccal delivery systems using hydrogels, Adv. Drug Del. Rev., 1993,11,179.
82. Ishida M., Machida Y., Nambu N. and Nagai T., New mucosal dosage form of insulin, Chem. Pharm. Bull., 1981, 29, 810.
83. Satoh K., Takayama K., Machida Y., Suzuki Y., Nakagaki M., and Nagai T., Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer., Chem. Pharm. Bull., 1989, 37,1366.
84. Gupta A., Garg S., and Khar R.K., Interpolymer complexation and its effect on bioadhesion strength and dissolution characteristics of buccal drug delivery systems, Drug Dev. Ind. Pharm., 1994, 20,315.
85. Anlar S., Capan Y., Guven O., Gogus A., Dlakara T. and Hincal A.A., Formulation and in-vitro-in vivo evaluation of buccoadhesive morphine sulfate tablets, Pharm. Res., 1994,11, 231.
86. Anders R. and Merkle H., Evaluation of laminated mucoadhesive patches for buccal drug delivery, Int. J. Pharm., 1989, 49,231.
87. Ishida M., Nambu N., and Nagai T., Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and carbopol, Chem. Pharm. Bull., 1982,30:980-984. (Pubitemid 13243534)
88. Guo J.H., Investigating the surface properties and bioadhesion of buccal patches, J. Pharm. Pharmacol., 1994, 46, 647.
89. Watanabe K., Yakou S., Takayama K., Machida Y. and Nagai T., Drug release behaviors from hydrogel prepared with water soluble dietary fibers, J. Pharm. Sci. Techn. Jpn., 1991, 51,29.
90. Anders R., Merkle H.P and Ziegler R., Buccal absorption of protirelin: an effective way to stimulate thyrotropin and prolactin, J. Pharm. Sci., 1983, 72,1481.
91. Veillard M.M., Longer M.A., Martens T.W. and Robinson J.R., Preliminary studies of oral mucosal delivery of peptide drugs, J. Control. Rel., 1987,6,123.
92. Park H. and Robinson J.R., Mechanisms of mucoadhesion of poly (acrylic acid) hydrogels, Pharm. Res., 1987, 4,457.
93. Garcia-Gonzalez N., Kellaway I., Blanco-Fuente H., Anguiano-Igea S., Delgado-Charro B., Otero-Espinar F., and Blanco-Mendez J., Design and evaluation of buccoadhesive metoclopramide hydrogels composed of poly(acrylic acid) crosslinked with sucrose, Int. J. Pharm., 1993,100, 65.
94. Leung S.S. and Robinson J.R., The contribution of anionic polymer structural features to mucoadhesion, J. Control. Rel., 1990,12,187.
95. Leung S. and Robinson J.R., Polymer structure features contributing to mucoadhesion: II., J. Control. Rel., 5, 1988, 223.
96. Bodde De Vries, M.E. & Junginger H.E., Mucoadhesive polymers for the buccal delivery of peptides, structure-adhesiveness relationships, J. Control. Rel., 1990,13, 225.
97. Cassidy J.P., Landzert N.M. and Quadros E., Controlled buccal delivery of buprenorphine, J. Control. Rel., 1993, 25, 21.
98. Benes L., Transmucosal, oral controlled-release, transdermal drug administration in human subjects: A crossover study with melatonin, J. Pharm. Sci., 1997,86,1115.
99. DeGrande G., Benes L., Horriere F., Karsenty F., LaCoste C., McQuinn R., Guo J., and Scherrer R. in eds. M.J. Rathbone, Oral Mucosal Drug Delivery, Marcel Dekker, Inc., New York, 1996, 285.
100. Nakane S., Kakumoto M., Yulimatsu K. and Chien Y.W., Oramucosal delivery of LHRH: Pharmacokinetic studies of controlled and enhanced transmucosal permeation, Pharm. Dev. Tech., 1996,1,251.
101. Nguyen-Xuan T., Towart R., Terras A., Jacques Y., Buri P., and Gurny R., Mucoadhesive semi-solid formulations for intraoral use containing sucralfate, Eur. J. Pharm. Biopharm., 1996, 43,133.
102. Nair M. and Chien Y.W., Development of anticandidal delivery systems: (II) Mucoadhesive devices for prolonged drug delivery in the oral cavity, Drug Dev.Ind. Pharm., 1996, 22, 243.
103. Taylan B., Yilmaz C., Guven O., Kes S., and Hincal A.A., Design and evaluation of sustained-release and buccal adhesive propranolol hydrochloride tablets, J. Control. Rel., 1996, 38,11.
104. Yukimatsu K., Nozaki Y., Makumoto M. and Ohta M., Development of a trans-mucosal controlled-release device for systemic of antianginal drugs pharmacokinetics and pharmacodynamics, Drug Dev. Ind. Pharm., 1994, 20, 503.
105. Shojaei A.H. and Li X., Novel copolymers of acrylic acid and poly ethylene glycol monomethylether monomethacrylate for buccal mucoadhesion: Preparation and surface characterization, Pharm. Res., 1995,12 (S1), S210.
106. Shojaei A.H. and Li X., Mechanisms of buccal mucoadhesion of novel copolymers of acrylic acid and polyethylene glycol monomethylether monomethacrylate, J. Control. Rel., 1997,47,151.
107. Choi H.K., Kim O.J., Jung C.K., Cho Y.J. and Cho C.S., Interpolymer complex prepared by template polymerization for transmucosal drug delivery, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 1997, 24,415.
108. Voorspoels J., Comhaire F., De Sy W. and Remon J.P., Buccal absorption of progesterone in the dog, Proceed. Int. Symp. Control. Rel. Bioact. Mater., 1997,24:185-186. (Pubitemid 27336470)
109. Squier C.A. and Hall B.K., The permeability of mammalian non-keratinized oral epithelia to horseraddish peroxidase applied in vivo and in vitro, Arch. Oral Biol., 1984, 29,45.
110. Cassidy J.P., Landcert N.M. and Quardos E., Controlled buccal delivery of buprenorphine, J.Control. Rel., 1993, 25, 21.
111. Dowty M.E., Irons B.K., Knuth K.E. Robinson J.R. Proceed. Int. Symp. Control. Rel. Bioact. Mater., 1990,17:226.
112. Tanaka M.Yanagibashi N, Fukuda H, Nagai T., Absorption of salicylic through the oral mucous membrane of hamster cheek pouch, Chem.Pharm. Bull., 1980, 28: 1056.
113. Collins P., Laffoon J. and Squier C.A., Comparative study of porcine oral epithelium, J. Dent. Res., 60:543, 1981.
114. Jimenez-Castellanos M.R., Zia H., Rhodes C.T., Drug Dev. Ind. Pharm., 1993: 19: 143.
115. Longer M.A., Ch'ng H.S., Robinson J.R. , J. Pharm. Sci., 1985: 74:406.
116. Siegal I.A., Surfactant-induced increase of permeability of rat oral mucosa to non-electolytes in vivo, Arch. Oral Biol., 1984, 29:13.
117. Beckett and Moffat, Correlation of partition coeficients in n-heptane aqueous systems with buccal absorption data for a series of amines and acids, J.Pharm. Pharmacol., 1969, 21, 144s.